[HT-07] Hot Topics 07 Innovative management can bring bright future for Parkinson's disease

[HT-07-3] An exploratory study on expanding cybernetic treatment from neuromuscular to Parkinson's disease

^○Takashi Nakajima¹, Ayano Matsui^2,5, Takashi Sakamoto³, Daisuke Nishida^4,5 (1.Dept. of Neurology, National Hospital Organization Niigata National Hospital, Japan, 2.Dept. of Orthopedics, National Center of Neurology and Psychiatry, 3.Dept. of Neurology, National Center of Neurology and Psychiatry, 4.Dept. of Rehabilitation, National Center of Neurology and Psychiatry, 5.Dept. of Rehabilitation, National Hospital Organization Niigata National Hospital)

Dr.Takashi Nakajima, MD, Ph.D., is a Neurologist and the Director of the National Hospital Organization Niigata National Hospital. He graduated from Niigata Univ. School of Medicine (1983). He became a resident and a research fellow of the Brain Research Institute, Niigata Univ. (1983-1984), and he completed the Ph.D. program of Niigata Univ. (1985-1991). He joined the National Institute of Mental Health, NIH (USA) as a Fogarty Fellow (1987-1989). He was an expert member of the Pharmaceutical, Medical Device and Food Committee, MHLW (2001-2004). Since 2004, he has been a guest lecturer of the Brain Research Institute, Niigata Univ., and a specialist of PMDA. His main research areas are Neurology, Neuro-rehabilitation, PRO, and Clinical Trial Design. He is a member of various medical societies, including the Japanese Society of Neurology (Specialist, Instructor), the Japan Society for Dementia Research (Specialist), and the Japanese Society for Genetic Counselling (Specialist).